Table 1.
Clinicopathologic characteristics of the whole participants.
| Characteristics | Training set | Test set | ||||
|---|---|---|---|---|---|---|
| HC | GC | p-value | HC | GC | p-value | |
| Total number | 161 | 144 | 22 | 22 | ||
| Male | 104 | 99 | 0.4427 | 12 | 12 | 1.0000 |
| Female | 57 | 45 | 10 | 10 | ||
| Age (mean, sd) | 55.9627 ± 11.1147 | 58.1389 ± 9.7798 | 0.1360 | 55.9091 ± 8.6845 | 56.0909 ± 8.0647 | 0.9430 |
| Weight (mean, sd) | 64.5404 ± 8.4609 | 63.7986 ± 7.9029 | 0.3216 | 64.9545 ± 7.5181 | 62.6818 ± 9.9350 | 0.3971 |
| Height (mean, sd) | 168.5963 ± 8.6822 | 169.3264 ± 8.3656 | 0.4193 | 167.9091 ± 8.1761 | 167.2273 ± 8.4173 | 0.7865 |
| BMI (mean, sd) | 22.6560 ± 2.0273 | 22.2415 ± 2.1597 | 0.0920 | 23.0368 ± 2.0542 | 22.4045 ± 3.0318 | 0.5416 |
| Systolic | 124.7019 ± 11.0152 | 125.7778 ± 8.0056 | 0.6186 | 122.8636 ± 8.5149 | 124.5909 ± 10.9225 | 0.5617 |
| Diastolic | 75.6770 ± 9.4846 | 74.4375 ± 8.1599 | 0.1732 | 72.8636 ± 9.6525 | 72.1364 ± 12.1275 | 0.4704 |
| I | 75 | 12 | ||||
| II | 39 | 6 | ||||
| III | 22 | 3 | ||||
| IV | 8 | 1 | ||||
HC, healthy control; GC, gastric cancer; BMI: body-mass index.